The Board of Directors of AnorMED Inc.
has recommended that shareholders vote in favor of the AnorMED slate of director
nominees and reject any slate of director nominees that may be proposed by a dissident
group of shareholders, represented by The Baker Group, holding approximately 23
percent of the Company's shares.